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Abstract
Introduction: Mycobacterium tuberculosis Beijing strains are frequently associated with tuberculosis outbreaks and drug
resistance. However, contradictory evidence and limited study generalizability make it difficult to foresee if the emergence
of Beijing strains in high-income immigrant-receiving countries poses an increased public health threat. The purpose of this
study was to determine if Beijing strains are associated with high risk disease presentations relative to other strains within
Canada.
Methods: This was a retrospective population-based study of culture-confirmed active TB cases in a major immigrant-
receiving province of Canada in 1991 through 2007. Of 1,852 eligible cases, 1,826 (99%) were successfully genotyped.
Demographic, clinical, and mycobacteriologic surveillance data were combined with molecular diagnostic data. The main
outcome measures were site of disease, lung cavitation, sputum smear positivity, bacillary load, and first-line
antituberculosis drug resistance.
Results: A total of 350 (19%) patients had Beijing strains; 298 (85%) of these were born in the Western Pacific. Compared to
non-Beijing strains, Beijing strains were significantly more likely to be associated with polyresistance (aOR 1.8; 95% CI 1.0–
3.3; p=0.046) and multidrug-resistance (aOR 3.4; 1.0–11.3; p=0.049). Conversely, Beijing strains were no more likely than
non-Beijing strains to be associated with respiratory disease (aOR 1.3; 1.0–1.8; p=0.053), high bacillary load (aOR 1.2; 0.6–
2.7), lung cavitation (aOR 1.0; 0.7–1.5), immediately life-threatening forms of tuberculosis (aOR 0.8; 0.5–1.6), and
monoresistance (aOR 0.9; 0.6–1.3). In subgroup analyses, Beijing strains only had a significant association with multidrug-
resistant tuberculosis (aOR 6.1; 1.2–30.4), and an association of borderline significance with polyresistant tuberculosis (aOR
1.8; 1.0–3.5; p=0.062), among individuals born in the Western Pacific.
Conclusion: Other than an increased risk of polyresistant or multidrug-resistant tuberculosis, Beijing strains appear to pose
no more of a public health threat than non-Beijing strains within a high-income immigrant-receiving country.
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Introduction
Since first being reported in 1995 (Beijing isolates) and 1996
(strain W) [1,2], the Beijing lineage of Mycobacterium tuberculosis (also
referred to as the East Asian lineage or Lineage 2) has garnered
much attention in international tuberculosis literature. The largest
genotype family of M. tuberculosis [3], Beijing strains account for
13% of strains globally and dominate the M. tuberculosis
epidemiology in some geographic areas [4,5]. In the Western
Pacific countries of China, Japan, South Korea and Vietnam, 54–
92% of M. tuberculosis case isolates are Beijing strains [1,6–10].
While other countries are only now experiencing an emergence of
Beijing lineage strains [4,11–15], China has had high endemic
levels of these strains for at least 60 years [16].
Active tuberculosis disease (TB) resulting from infection with
Beijing strains has frequently been associated with TB outbreaks
[2,11], antituberculosis drug resistance [4,8,17,18], treatment
failure [19] and relapse [19–21]. Of particular concern is the
association between Beijing strains and multidrug-resistant TB
(MDR-TB) [18,22,23]. Beijing strains also appear to have an
enhanced ability to circumvent immunity induced through bacille
Calmette-Gue ´rin (BCG) vaccination, potentially resulting in a
selective advantage of these strains in populations with high rates
of BCG vaccination [24–26].
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between Beijing strains and either BCG vaccination status [27] or
various presentations of TB [4,8,23,28–32]. This inter-study
variability may result from the heterogeneous distribution of
Beijing sublineages; programmatic differences in TB control;
inherited and acquired host factors; socioeconomic circumstances;
chance; and other factors [33–35]. Furthermore, little clarity is
afforded by evidence of genotypic diversity within the M.
tuberculosis species because it remains inconclusive as to whether
or not genotypic diversity meaningfully influences the outcome of
infection in vivo [36]. The bottom line – the epidemiologic
significance of Beijing lineage strains in the human population
remains largely ambiguous.
Contradictory evidence within the Beijing literature and the
often limited generalizability of studies make it difficult to foresee
whether the emergence of Beijing lineage strains in high-income
immigrant-receiving countries with low TB incidence (hereafter
referred to as immigrant-receiving countries for brevity) poses an
increased public health threat. This study sought to determine if
the Beijing lineage of M. tuberculosis strains was associated with
more high risk presentations of active TB than other strains in
Canada, a country with one of the highest levels of immigration
per capita internationally and in which a quarter of the foreign-
born population has originated from the Western Pacific [37,38].
A secondary objective was to determine if Beijing disease
presentation varied in relation to patients’ age or population
group.
Methods
Ethics Statement
Study approval was obtained from the University of Alberta
Health Research Ethics Board. The need for patient’s informed
consent was waived by the University of Alberta Health
Research Ethics Board as the retrospective analysis of anony-
mous and routine surveillance data did not require direct
patient contact.
Study Population
This retrospective cohort study investigated cases of active TB
diagnosed among residents of the immigrant-receiving province of
Alberta, Canada (population of 3,290,355 in 2006) from January
1, 1991 through June 30, 2007. Canadian-born individuals were
born in Canada or born in a foreign country to Canadian parents;
all others were foreign-born. Aboriginals (defined in this study as
First Nations peoples registered with Indian and Northern Affairs
Canada) were distinguished from Canadian-born ‘other’ (non-
Status Indian, Me ´tis, Inuit, and non-Aboriginal individuals) due to
a marked disparity in the TB rates of these groups. Foreign-born
individuals were grouped into those born in the Western Pacific
region (Table S1) [39] and those born elsewhere (foreign-born
‘other’) given the high prevalence of Beijing strains in the Western
Pacific.
Foreign- and Canadian-born population estimates were ob-
tained from Canadian censuses (1991, 1996, 2001 and 2006) using
customized reports from Statistics Canada. To calculate person-
years, these census estimates were combined with estimates
between census years as calculated with linear interpolation as
well as the population estimates for 2007 which were obtained
through linear extrapolation. Estimates for Canadian-born ‘other’
were those derived from the censuses minus annual Aboriginal
population estimates as obtained directly from Indian and
Northern Affairs Canada.
Cases
All culture-confirmed active TB cases diagnosed during the
study period as per the Alberta Tuberculosis Registry were eligible
for study inclusion. Demographic and clinical data from the TB
registry were combined with data from the Provincial Laboratory
for Public Health (‘Provincial Laboratory’) where all of the
mycobacteriology in the province is performed.
Cases were grouped by site (respiratory versus non-respiratory
disease) and severity (immediately life-threatening forms of TB
versus other forms of TB). Respiratory cases consisted of: primary,
pleural, pulmonary or ‘other respiratory’ TB (ICD-9 codes 010–
012) [40]; miliary TB (ICD-9 code 018) with culture-positive
respiratory specimen(s); and cases with concurrent respiratory and
non-respiratory TB. Miliary TB and TB involving the central
nervous system (CNS) (ICD-9 code 013) comprised immediately
life-threatening forms of TB.
The infectiousness of respiratory cases was evaluated in relation
to sputum smear positivity and the presence of lung cavitation on
chest radiograph. Semi-quantitative scores for acid-fast bacilli
(AFB) load on baseline sputum smears were also analyzed for
respiratory cases diagnosed after 1992 that had positive sputum
smears collected on or before the date of diagnosis (the start date of
treatment); this data was unavailable for cases in 1991–1992.
Monoresistant-TB refers to resistance to a single first-line
antituberculosis drug, namely isoniazid (INH), rifampin (RMP),
pyrazinamide (PZA), ethambutol (EMB), or streptomycin (STM).
Polyresistance was defined as resistance to two or more first-line
antituberculosis drugs but not to both INH and RMP; resistance
to at least INH and RMP constituted MDR-TB. ‘Any first-line
drug resistance’ includes monoresistant-TB, polyresistant-TB, and
MDR-TB.
Cases were also dichotomized as being a new active case (first
episode of TB) or retreatment TB case (history of a previous
episode of TB).
Laboratory Methods
The Provincial Laboratory conducted all routine mycobacter-
iologic studies as per the Canadian Tuberculosis Standards [40]
and completed routine DNA fingerprinting as previously described
using IS6110 restriction fragment length polymorphism (RFLP)
typing and, for isolates with five copies or less of IS6110,
spoligotyping [41]. Clusters were defined as groups of two or more
patients with identical RFLP patterns and, for isolates with five or
fewer copies of IS6110, identical spoligotype patterns.
Isolates were assigned to an M. tuberculosis lineage according to
the PCR-based detection of large sequence polymorphisms (LSPs)
[31,42,43]. The Provincial Laboratory analyzed LSPs with an ABI
7000 Real-Time PCR machine (Azco Biotech, Inc., San Diego,
CA) using standard conditions and published TaqMan
TM primers
and probes [42,43]. Isolates with a deletion of RD105 were
categorized as Beijing lineage strains and all others as non-Beijing
lineage strains (hereafter referred to as Beijing strains and non-
Beijing strains). Accordingly, this methodology assigned both
classical Beijing strains (those with concurrent deletions of RD105
and RD207, the latter resulting in the characteristic ‘Beijing’
spoligotype pattern consisting of a loss of spacers 1 to 34 and a
presence of $3 spacers among spacers 35–43) [3] and ancestral
members of this family (those with a deletion of RD105 but
without a concurrent deletion of RD207) to the same lineage [44].
The lineage assignment of a convenience sample of isolates was
confirmed through spoligotyping at the Provincial Laboratory or
through LSP analyses at extra-provincial laboratories (M. Behr,
McGill University; C. Pepperell, Stanford University).
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Agreement in the lineage assignment of isolates between the
initial LSP analysis and confirmatory testing was assessed with the
Kappa co-efficient. The incidence rate ratio (RR) was used to
compare TB rates between Beijing and non-Beijing strains overall
as well as between groups defined on the basis of sex, age at
diagnosis, and population group within each lineage. Associations
between lineage and various demographic and disease variables
were evaluated with binary or multinomial logistic regression; p-
values correspond to the likelihood ratio chi-square test in
bivariate models [45]. Sex, age at diagnosis, and population
group frequently confounded the associations between M.
tuberculosis lineage and disease presentation (.15% change in the
estimated coefficient) and were therefore included in multivariate
analyses [46]. Additional adjustment was completed to ensure that
associations with disease presentation were independent of HIV
co-infection and associations with drug resistance were not
confounded by previous TB or clustering. Evidence for effect
modification within multivariate analyses was based on the
likelihood ratio test [45]. Subgroup analysis was planned a priori
to enhance the transparency of potential differences in Beijing
disease presentation across population group (Western Pacific
versus others) and age strata [46]. All statistical tests used a 5%
level of significance and 95% confidence intervals (CI) were
calculated where appropriate; p-values that were p.0.05 but
p,0.07 were considered to be of borderline statistical significance.
Statistical analyses were conducted with Stata/IC 11 (StataCorp.
2009. Stata Statistical Software: Release 11. College Station, TX:
StataCorp LP).
Results
The Alberta TB Registry was notified of 1852 culture-
confirmed M. tuberculosis cases from 1991–2007 and isolates from
1827 (99%) cases were available for LSP analysis. Confirmatory
genotyping was completed on a sample of 535 (29%) cases using
spoligotyping (n=412), LSP analysis at an external laboratory
(n=98) or both spoligotyping and LSP analysis (n=25). One case
was subsequently removed from the study due to discordance in
lineage assignment based on initial and confirmatory LSP analyses
(K=0.995; p,0.001). The demographic attributes of included
and excluded cases were similar (Table S2). The convenience
sample included 119 (22%) cases with Beijing lineage strains and
110 (92%) of these were spoligotyped. All of these Beijing lineage
isolates were found to have characteristic Beijing spoligotype
patterns [3] and no ‘‘pseudo-Beijing’’ isolates (described as isolates
with an intact RD105 but with a characteristic Beijing spoligotype
pattern) [47] were identified.
Of the 1826 cases included in the study, 350 (19%) were Beijing
strains and the associated incidence rate was 0.2 (95% CI 0.2–0.3)
times that of other strains (rates of 0.7 and 3.1 per 100,000 person-
years, respectively) (Table 1). The lineages also had marked
differences in the distribution of cases by age (p=0.004) and
population group (p,0.0001) but not sex (p=0.398).
Overall, 3% of Canadian-born patients and 28% of foreign-
born patients had Beijing strains. Foreign-born individuals
accounted for 330 (94%) Beijing cases and 298 (90%) of these
were born in the Western Pacific (Table 1). More specifically, 282
(81%) Beijing cases were born in the Western Pacific’s Beijing
‘hotspots’ of China (including Hong Kong, Macau, and Taiwan),
Japan, South Korea, and Vietnam. Consequently, the incidence
rate of Beijing strains among individuals born in the ‘hotspots’ was
nine (95% CI 5.6–16.5) times that of persons born elsewhere in the
Western Pacific, 37 (95% CI 25.5–54.8) times that of foreign-born
‘other’, and 417 (95% CI 265.0–693.4) times that of Canadian-
born persons. It is also noteworthy that only 20 Canadian-born
cases had Beijing strains (five being Aboriginals) and that the
proportion of Beijing strains in the Canadian-born non-Aboriginal
group was significantly higher than that of Aboriginal peoples (OR
0.4; CI 0.1–1.0; p=0.046).
There was an overall trend of declining annual incidence rates
of Beijing strains (Figure 1A). This primarily reflected the
reduction in Beijing incidence rates in the foreign-born Western
Pacific (Figure 1B) given the trend of slightly increasing Beijing
rates in the foreign-born ‘other’ (Figure 1C) and the inconsequen-
tial rates of Beijing strains in the Canadian-born (Figure 1D).
Apart from a pronounced reduction in the incidence rates of non-
Beijing strains in the Canadian-born (Figure 1D), the trends in the
annual incidence rates of non-Beijing strains mimicked that of
Beijing strains both overall (Figure 1A) and within each foreign-
born group (Figure 1B and Figure 1C).
The DNA fingerprint patterns of M. tuberculosis isolates from
1821 (99.7%) patients were available of which 348 (19%) were
Beijing strains and 1473 (81%) were non-Beijing strains. Sixty
(17%) patients with Beijing strains were associated with 22 clusters
(ranging in size from 2 to 6 patients per cluster) compared to 560
(38%) patients with non-Beijing strains in 139 clusters (2 to 43
patients per cluster), the proportion of clustered Beijing cases being
significantly lower than that of non-Beijing cases (p,0.0001).
Although a smaller proportion of Beijing cases were clustered
relative to non-Beijing cases among patients born in the Western
Pacific (15.5% versus 27.5%, p,0.0001) and those born in
Canada (35.0% versus 62.0%, p=0.015), a similar proportion of
clustering was observed for Beijing and non-Beijing cases among
foreign-born patients who were born outside of the Western
Pacific (21.9% versus 15.6%, p=0.346). Thirteen (59%) of the 22
Beijing clusters consisted exclusively of foreign-born Western
Pacific patients and all but one of these were limited to patients
born in Beijing ‘hotspot’ countries. Six of the remaining nine
Beijing clusters also involved patients born in the Western Pacific
‘hotspot’ countries as well as either a Canadian-born patient (two
clusters), a foreign-born ‘other’ patient (three clusters) or both a
Canadian-born patient and a foreign-born ‘other’ patient (one
cluster). The three exceptions were one cluster composed of three
Canadian-born individuals (one Aboriginal person), one cluster
composed of two individuals born in the same country within the
former Union of Soviet Socialist Republics, and one cluster
composed of a Canadian-born patient and a foreign-born ‘other’
(India) patient.
Respiratory TB, sputum smear positivity, high bacillary load or
lung cavitation were no more likely among Beijing cases than non-
Beijing cases in unadjusted analysis (Table 2). However, after
controlling for the demographic variables of sex, age at diagnosis
and population group, an increased likelihood of respiratory TB
among Beijing cases was of borderline significance (Table 2).
Compared to non-Beijing cases, Beijing cases were not
associated with immediately life-threatening forms of TB in
unadjusted or adjusted analysis (Table 2).
All isolates were tested for INH, RMP, and EMB susceptibility
and all but one isolate for STM susceptibility. As well, 1609 (88%)
isolates were tested for PZA susceptibility (50% in 1991–1993 and
99% in 1994–2007). Overall, 1592 (87%) isolates were pan-
sensitive to the antituberculosis drugs for which they were
screened. Beijing strains were not associated with an increased
likelihood of any first-line antituberculosis drug resistance or
monoresistance in adjusted analysis (Table 2). Rather, polyresis-
tance and MDR-TB were two to three times more likely in Beijing
isolates than other isolates independent of demographic factors,
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These associations between Beijing strains and drug resistance
were not confounded by previous TB or clustering (data not
shown). Of potential clinical importance was the finding that six
(86%) of the seven Beijing isolates with MDR were also resistant to
at least two other first-line drugs (EMB, PZA and/or STM) and all
but one of these were diagnosed among individuals born in the
Beijing ‘hotspots’.
A total of 903 (49%) TB patients had consented to HIV
antibody testing. However, as all co-infected patients were aged
15–64 years when diagnosed with TB, analysis in relation to HIV
status was subsequently limited to the 705 TB cases in this age
group who had undergone HIV testing. Beijing strains were
associated with 103 (15%) of these TB cases, five (5%) of which
were HIV co-infected. Among TB cases with non-Beijing strains,
46 (8%) of 556 were co-infected with HIV. Relative to non-Beijing
strains, Beijing strains were not associated with TB-HIV co-
infection in unadjusted or adjusted analysis (Table S3). After
adjusting for HIV status and demographic variables, there was
also no association between Beijing strains and disease presenta-
tion apart from that of polyresistance (aOR 2.8; 95% CI 1.2–6.7)
(Table S3).
The associations between Beijing strains and disease presenta-
tion were not consistent in all subgroups (Table 3 and Table 4). An
association between Beijing strains and MDR-TB was only noted
in the foreign-born Western Pacific (Table 3). Additionally, Beijing
strains were associated with polyresistance in those aged ,35 years
at diagnosis (Table 4) whereas this association was of borderline
significance among individuals born in the Western Pacific
(Table 3). As well, Beijing strains were associated with sputum
smear-positive respiratory TB among those aged ,35 years at
diagnosis but not those aged $35 years at diagnosis (Table 4).
Discussion
Beijing lineage strains, representing 19% of TB cases in the
major-immigrant receiving province of Alberta, have a definite
presence within Canada. This presence is largely limited to
persons born in the Western Pacific and especially its Beijing
‘hotspots’ of China, South Korea, Japan and Vietnam. Individuals
born in the ‘hotspots’ accounted for 81% of Beijing isolates, the
rate being nine to 417 times that of the other groups. In particular,
Beijing strains had a relatively minimal impact on the incidence of
TB in the Canadian-born (incidence of 0.05/100,000 person-
years). These findings generally follow that of other low TB
incidence immigrant-receiving countries [15,32,48–50] and fur-
ther support the well-established correlation between M. tuberculosis
lineage and the host’s country of origin/birth [31,42,51].
Notwithstanding the emergence of Beijing lineage strains in
immigrant-receiving countries, there is minimal evidence overall
from these countries or this study to indicate that Beijing strains
significantly and independently influence the presentation of TB
apart from drug resistance [31,32,48,50,52–54]. Beijing strains
were significantly more likely than non-Beijing strains in the
current study to have polyresistance to first-line antituberculosis
drugs independent of demographic factors, clustering, a previous
history of TB, or HIV status. A type of polyresistance, MDR-TB,
was also three times more likely among Beijing isolates in adjusted
analyses. The association between Beijing strains and MDR-TB in
immigrant-receiving countries [32,48,50] is of epidemiologic and
clinical significance given that MDR-TB is one of the greatest
threats to global TB control. This is exemplified in Germany
where the importation of Beijing strains appears responsible for an
increasing occurrence of MDR-TB [22]. The United States’
experience with the MDR strain W also highlights the importance
of sustaining effective TB control programs in low incidence
settings given the potential for the rapid dissemination of drug-
resistant strains of M. tuberculosis in healthcare settings, correctional
facilities and elsewhere, especially among persons at high risk for
TB (e.g. HIV infected persons) [2,55].
The finding in this study of a borderline association between
Beijing strains and respiratory TB accords with associations
between these strains and pulmonary TB in studies completed in
Table 1. Incidence of Beijing and Non-Beijing strains of M. tuberculosis in Alberta, 1991–2007.
Beijing Strains Non-Beijing Strains
Characteristic PYRs* No. (%) Rate{ RR (95%CI) No. (%) Rate{ RR (95%CI)
Sex
Female 235.4 161 (46.0) 0.7 1.0 716 (48.5) 3.0 1.0
Male 235.7 189 (54.0) 0.8 1.2 (0.9, 1.5) 760 (51.5) 3.2 1.1 (1.0, 1.2)
Age at Diagnosis
,35 years 243.9 104 (29.7) 0.4 1.0 438 (29.7) 1.8 1.0
35–64 years 180.9 109 (31.1) 0.6 1.4 (1.1, 1.9) 583 (39.5) 3.2 1.8 (1.6, 2.0)
.64 years 46.3 137 (39.1) 3.0 6.9 (5.3, 9.1) 455 (30.8) 9.8 5.5 (4.8, 6.3)
Population Group
CB Other 381.4 15 (4.3) 0.04 1.0 324 (22.0) 0.8 1.0
CB Aboriginal 13.6 5 (1.4) 0.4 9.4 (2.7, 27.1) 288 (19.5) 21.2 25.0 (21.2, 29.4)
FB Other 56.5 32 (9.1) 0.6 14.6 (7.7, 29.0) 469 (31.8) 8.4 9.9 (8.6, 11.4)
FB Western Pacific 19.6 298 (85.1) 14.6 371.7 (221.7, 672.5) 395 (26.8) 19.4 22.8 (19.6, 26.5)
Total 471.1 350 (100.0) 0.7 1476 (100.0) 3.1
Abbreviations: PYRs, person-years of observation; RR, incidence rate ratio; CI, confidence interval; CB, Canadian-born; FB, foreign-born; WP, Western Pacific.
*Estimates of the foreign-born and Canadian-born populations were derived from customized Statistics Canada census reports. Estimates for Canadian-born ‘other’
were those derived from the censuses minus the annual population of Canadian-born Aboriginal peoples as obtained directly from Indian and Northern Affairs Canada.
{Crude incidence rate per 100,000 person-years.
doi:10.1371/journal.pone.0038431.t001
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found that this similarity persists when site of disease is changed
from ‘respiratory’ (aOR 1.3; CI 1.0–1.8; p=0.053) to ‘pulmonary’
(aOR 1.3; CI 1.0–1.7; p=0.055). The association of Beijing strains
with extrathoracic TB in the United States [53] appears unique
compared to other high-income immigrant-receiving countries
[15,31,54] and presumably results from variability in the
distribution of Beijing sublineages or sample size limitations [56].
Although the relatively consistent association between Beijing
lineage strains and respiratory/pulmonary TB has potentially
important public health consequences, it is equally important that
these strains have not been associated with increased infectiousness
in terms of lung cavitation, sputum smear positivity or bacillary
load in this and similar studies in immigrant-receiving countries
[52,53,57]. In the current study there was also no association
between Beijing strains and increased disease severity in relation to
immediately life-threatening forms of TB. Further, genotyping
analysis found that the likelihood of DNA fingerprint clustering
was significantly less among Beijing cases than non-Beijing cases
both overall and when limited to patients born in the Western
Pacific. Together, these findings suggest that the commonly
hypothesized hypervirulence and increased transmissibility of
Beijing strains is largely unfounded and/or of minimal public
health consequence in Alberta, and presumably in other immi-
grant-receiving areas, when effective TB control programs are in
place. By extension, it may have been mere coincidence that
Beijing strains led to MDR-TB outbreaks in immigrant-receiving
countries as MDR variants in other lineages could have been
equally successful, all other factors being equal.
Host-pathogen interactions or other population-specific factors
plausibly account for the varied disease presentations highlighted in
subgroup analyses. Of interest is that Beijing strains were associated
with MDR-TB, polyresistant TB and/or sputum smear-positive
disease among individuals born in the Western Pacific or those aged
less than 35 years at diagnosis given that similar groups were
identified as high-yield targets for routine screening for latent TB
infection in Canada [58]. It may therefore be judicious to also take
phylogeographical lineagesof M. tuberculosis into considerationwhen
defining targets for systematic screening for latent TB infection.
Aboriginal peoples are a highly vulnerable population for TB in
Canada and are a significant source of TB transmission
[40,41,59]. The minimal incidence of Beijing strains in Aboriginal
peoples further substantiates the growing body of evidence that
indicates that immigration has a minimal impact on the
epidemiology of TB in the Canadian-born population [41,60,61].
Nevertheless, immigration is a decisive factor in the prevalence of
Beijing strains within immigrant-receiving countries. For example,
the smaller proportion of Beijing strains in the city of Montreal,
Canada compared to this study (9% and 19%, respectively)
correlates to a substantially smaller proportion of immigrants from
Figure 1. Annual incidence rates of Beijing and non-Beijing lineage strains by population group. In each panel: rates are per 100,000
person-years (y-axis); time corresponds to the year of diagnosis (x-axis); bars with dark grey shading are cases with Beijing strains; and bars with light
grey shading are cases with non-Beijing strains. The panels represent total cases (panel A) as well as cases within the foreign-born Western Pacific
(panel B), foreign-born ‘other’ (panel C) and Canadian-born (panel D) populations.
doi:10.1371/journal.pone.0038431.g001
Table 2. Association between M. tuberculosis lineage and disease presentation in Alberta, 1991 to mid-2007.
Beijing (n=350) Non-Beijing (n=1476)
Disease Presentation No. (%) No. (%) OR (95% CI)* aOR (95% CI){
Respiratory TB 259 (74.0) 1122 (76.0) 0.9 (0.7, 1.2) 1.3 (1.0, 1.8)**
Sputum smear positive{ 112 (45.9) 538 (50.9) 0.8 (0.6, 1.1) 1.1 (0.8, 1.5)
High bacillary load1 16 (29.6) 89(33.3) 0.8 (0.4, 1.6) 1.2 (0.6, 2.7)
Lung cavitation 52 (14.9) 268 (18.2) 0.8 (0.6, 1.1) 1.0 (0.7, 1.5)
Immediately life-threatening TB 16 (4.6) 99 (6.7) 0.7 (0.4, 1.1) 0.8 (0.5, 1.6)
Any first-line drug resistance 73 (20.9) 161 (10.9) 2.2 (1.6, 2.9) 1.2 (0.8, 1.6)
Monoresistance 41 (11.7) 120 (8.1) 1.6 (1.1, 2.4) 0.9 (0.6, 1.3)
INH 11 (3.1) 48 (3.3) 1.0 (0.5, 2.0) 0.4 (0.2, 0.9)
RMP 0 0 – –
PZA 1 (0.3) 8 (0.6) 0.4 (0.2, 0.6) 0.7 (0.4, 1.2)
EMB 0 2 (0.1) – –
STM 29 (8.3) 62 (4.2) 2.2 (1.4, 3.5) 1.4 (0.8, 2.3)
Polyresistance 25 (7.1) 34 (2.3) 3.5 (2.0, 5.9) 1.8 (1.0, 3.3){{
MDR-TB 7 (2.0) 7 (0.5) 4.7 (1.7, 13.6) 3.4 (1.0, 11.3){{
Abbreviations: OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval; INH, isoniazid; RMP, rifampin; PZA, pyrazinamide; EMB, ethambutol; STM, streptomycin;
MDR-TB, multidrug-resistant TB.
*Non-Beijing strains are the reference group; –, logistic regression could not be completed due to cell count(s) of zero.
{Association between Beijing lineage and each disease presentation after adjusting for sex, age, and population group; non-Beijing strains are the reference group.
{There were 1301 respiratory TB cases with data related to airway secretions, 1057 (81.2%) and 244 (18.8%) being attributed to non-Beijing and Beijing lineages,
respectively.
1There were 321 respiratory TB cases diagnosed after 1992 that had sputum smear-positive specimens collected on or before the date of diagnosis.
**p=0.053.
{{p=0.046.
{{p=0.049.
doi:10.1371/journal.pone.0038431.t002
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[31,62]. Geographic areas with a considerable proportion of
immigrants from countries dominated by Beijing strains will
therefore predictably experience an increased emergence of Beijing
strains with epidemiologic patterns not unlike the region of origin.
This is one of the most comprehensive epidemiologic studies of
Beijing strains in a high-income immigrant-receiving country to
date and is the foremost study of its kind in Canada. The inclusion
of a measure of pathogen load was a distinguishing feature of this
study that provided further insight into the possible association
between M. tuberculosis lineage and level of infectiousness. The
accuracy of strain classification in this study was enhanced through
the use of an unambiguous and validated genotyping methodology
[31,42,43] as well as secondary genotyping on a substantial sample
Table 3. Association between M. tuberculosis lineage and disease presentation based on population group.
Foreign-born Western Pacific All Others*
Beijing Non-Beijing Beijing Non-Beijing
(n=298) (n=395) (n=52) (n=1081)
Disease Presentation No. (%) No. (%) aOR (95% CI){ No. (%) No. (%) aOR (95% CI){
Respiratory TB 214 (71.8) 256 (64.8) 1.2 (0.8, 1.7) 45 (86.5) 866 (80.1) 1.6 (0.7, 3.6)
Sputum smear-positive{ 95 (47.3) 91 (38.1) 1.5 (1.0, 2.1)1 17 (39.5) 447 (54.7) 0.6 (0.3, 1.0)**
High bacillary load{{ 12 (28.6) 9 (19.6) 1.7 (0.6, 4.7) 4 (33.3) 80 (36.2) 0.8 (0.2, 2.7)
Lung cavitation 43 (14.4) 54 (13.7) 1.1 (0.7, 1.7) 9 (17.3) 214 (19.8) 0.8 (0.4, 1.6)
Immediately life-threatening TB 13 (4.4) 20 (5.1) 0.8 (0.4, 1.6) 3 (5.8) 79 (7.3) 0.8 (0.2, 2.7)
Any first-line drug resistance 67 (22.5) 87 (22.0) 1.1 (0.8, 1.6) 6 (11.5) 74 (6.8) 1.6 (0.6, 3.9)
Monoresistance 37 (12.4) 66 (16.7) 0.8 (0.5, 1.3) 4 (7.7) 54 (5.0) 1.5 (0.5, 4.3)
Polyresistance 23 (7.7) 19 (4.8) 1.8 (1.0, 3.5){{ 2 (3.9) 15 (1.4) 2.5 (0.5, 11.3)
MDR-TB 7 (2.4) 2 (0.5) 6.1 (1.2, 30.4) 0 5 (0.5) –
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; TB, tuberculosis; MDR-TB, multidrug-resistant tuberculosis; –unable to calculated.
*Individuals born outside of the Western Pacific, including Canadian-born Aboriginals and Canadian-born non-Aboriginals.
{Independent of sex and age at diagnosis; non-Beijing strains are the reference group.
{Of respiratory cases, 440 cases among those born in the Western Pacific and 860 cases among those born elsewhere had smear microscopy data.
1p=0.057.
**p=0.069.
{{Sputum smear positive specimens were collected for 88 foreign-born Western Pacific and 233 ‘Other’ respiratory TB cases.
{{p=0.062.
doi:10.1371/journal.pone.0038431.t003
Table 4. Association between M. tuberculosis lineage and disease presentation based on age at diagnosis.
,35 years at diagnosis $35 years at diagnosis
Beijing Non-Beijing Beijing Non-Beijing
(n=104) (n=438) (n=246) (n=1038)
Disease Presentation No. (%) No. (%) aOR (95% CI)* No. (%) No. (%) aOR (95% CI)*
Respiratory TB 73 (70.2) 319 (72.8) 1.6 (0.9, 2.7) 186 (75.6) 803 (77.4) 1.3 (0.9, 1.9)
Sputum smear-positive{ 34 (48.6) 128 (42.5) 1.9 (1.0, 3.4){ 78 (44.8) 410 (54.3) 0.9 (0.6, 1.4)
High bacillary load1 7 (36.8) 18 (31.6) 8.1 (0.9, 74.6) 9 (25.7) 71 (33.8) 0.9 (0.3, 2.2)
Lung cavitation 23 (22.1) 81 (18.5) 1.7 (1.0, 3.1)I 29 (11.8) 187 (18.0) 0.7 (0.5, 1.2)
Immediately life-threatening TB 4 (3.8) 15 (3.4) 1.5 (0.4, 5.1) 12 (4.9) 84 (8.1) 0.7 (0.4, 1.5)
Any first-line drug resistance 31 (29.8) 72 (16.4) 1.3 (0.8, 2.3) 42 (17.1) 89 (8.6) 1.0 (0.6, 1.5)
Monoresistance 15 (14.4) 54 (12.3) 0.8 (0.4, 1.6) 26 (10.6) 66 (6.4) 0.8 (0.5, 1.4)
Polyresistance 13 (12.5) 14 (3.2) 3.1 (1.3, 7.5) 12 (4.9) 20 (1.9) 1.1 (0.5, 2.4)
MDR-TB 3 (2.9) 4 (0.9) 2.4 (0.5, 12.2) 4 (1.6) 3 (0.3) 6.1 (0.9, 42.7)
Abbreviations: aOR, adjusted odds ratio, CI, confidence interval; TB, tuberculosis; MDR-TB, multidrug-resistant tuberculosis; –unable to calculate.
*Independent of sex and origin; non-Beijing strains are the reference group.
{Of respiratory cases, 371 cases among those aged ,35 years and 929 cases among those aged #35 years had smear microscopy data.
{p=0.042.
1There were 76 respiratory TB cases diagnosed after 1992 that had sputum smear positive specimens collected on or before the date of diagnosis among those born in
the Western Pacific and 245 cases among those born elsewhere.
Ip=0.072.
doi:10.1371/journal.pone.0038431.t004
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the provincial TB registry and Provincial Laboratory also
minimized selection and information bias.
Study limitations include the relatively small number of
polyresistant and MDR isolates as well as the limited number of
Beijing cases with TB-HIV co-infection, the associated estimates
having limited precision. Generalizability of the study findings to
other immigrant-receiving countries may be limited by differences
in immigration patterns, immigration screening practices, and TB
control programs. Within Canada, the study findings are
anticipated to be especially relevant to the other major
immigrant-receiving provinces of Ontario and British Columbia
where approximately 20% and 40%, respectively, of immigrants
were born in the Western Pacific [38,62].
In conclusion, there is little evidence apart from an increased
risk of polyresistance or multidrug-resistance to indicate that
Beijing strains pose any more of a public health threat than other
M. tuberculosis strains within a low TB incidence immigrant-
receiving country with effective TB control practices in place.
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